Valuation IDEXX Laboratories, Inc.
Stocks
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Nasdaq
04:00:00 2026-10-14 pm EDT
|
5-day change | 1st Jan Change | ||
| 529.01 USD | +1.67% |
|
+4.41% | -21.81% |
| Oct. 12 | KeyBanc Initiates IDEXX Laboratories at Sector Weight | MT |
| Sep. 30 | IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI | MT |
Company Valuation: IDEXX Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 55,833 | 33,786 | 46,098 | 33,854 | 54,022 | 41,676 | - | - |
| Change | - | -39.49% | 36.44% | -26.56% | 59.57% | -22.85% | - | - |
| Enterprise Value (EV) 1 | 56,612 | 35,022 | 46,592 | 34,434 | 54,690 | 42,044 | 41,579 | 40,779 |
| Change | - | -38.14% | 33.04% | -26.09% | 58.83% | -23.12% | -1.11% | -1.92% |
| P/E | 76.6x | 50.8x | 55.2x | 38.7x | 51.7x | 35.8x | 31.7x | 28x |
| PBR | 82.6x | 55.6x | 31x | 21.6x | 34.1x | 21x | 15.6x | 11.4x |
| PEG | - | -7.66x | 2.2x | 6.38x | 2.3x | 2.8x | 2.4x | 2.1x |
| Capitalization / Revenue | 17.4x | 10x | 12.6x | 8.69x | 12.6x | 8.83x | 8.11x | 7.43x |
| EV / Revenue | 17.6x | 10.4x | 12.7x | 8.83x | 12.7x | 8.9x | 8.09x | 7.27x |
| EV / EBITDA | 54.6x | 34.7x | 38.4x | 28.1x | 36.3x | 24.9x | 22.4x | 19.8x |
| EV / EBIT | 60.7x | 39x | 42.5x | 30.5x | 40.2x | 27.6x | 24.6x | 21.6x |
| EV / FCF | 89x | 88.9x | 60.3x | 42.6x | 51.7x | 35.9x | 31.7x | 27.7x |
| FCF Yield | 1.12% | 1.13% | 1.66% | 2.35% | 1.93% | 2.79% | 3.15% | 3.61% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 8.6 | 8.03 | 10.06 | 10.67 | 13.08 | 14.77 | 16.69 | 18.91 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3,215 | 3,367 | 3,661 | 3,898 | 4,304 | 4,722 | 5,139 | 5,606 |
| EBITDA 1 | 1,037 | 1,011 | 1,212 | 1,225 | 1,505 | 1,686 | 1,858 | 2,061 |
| EBIT 1 | 932 | 898.8 | 1,097 | 1,128 | 1,360 | 1,526 | 1,692 | 1,888 |
| Net income 1 | 744.8 | 679.1 | 845 | 887.9 | 1,059 | 1,178 | 1,313 | 1,470 |
| Net Debt 1 | 779.2 | 1,236 | 493.9 | 579.3 | 667.8 | 368 | -97.34 | -896.8 |
| Reference price 2 | 658.46 | 407.96 | 555.05 | 413.44 | 676.53 | 529.01 | 529.01 | 529.01 |
| Nbr of stocks (in thousands) | 84,794 | 82,817 | 83,052 | 81,885 | 79,851 | 78,781 | - | - |
| Announcement Date | 2/2/22 | 2/6/23 | 2/5/24 | 2/3/25 | 2/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 35.83x | 8.9x | 24.94x | -.--% | 41.68B | |
| 30.38x | 4.03x | 15.56x | 2.5% | 178B | |
| 20.17x | 3.63x | 13.01x | 2.99% | 121B | |
| 21.93x | 4.3x | 15.02x | 1.28% | 108B | |
| 26.23x | 2.58x | 10.35x | 2.73% | 75.7B | |
| 18.44x | 0.21x | 13.38x | 0.71% | 64.15B | |
| 30.93x | 7.69x | 19.79x | 1.29% | 53.49B | |
| 36.4x | 3.49x | 11.96x | 2.08% | 51.45B | |
| 33.54x | 5.88x | 18.45x | -.--% | 31.5B | |
| 48.27x | 1.33x | 12.29x | 0.2% | 31.52B | |
| Average | 30.21x | 4.20x | 15.48x | 1.38% | 75.62B | |
| Weighted average by Cap. | 27.74x | 3.99x | 14.93x | 1.82% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- IDXX Stock
- Valuation IDEXX Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
